DREAMM-7
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
DREAMM-7
Jul 28, 2024, 12:28 |
Insight
Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…
Jul 14, 2024, 02:56 |
Drugs
Belamaf-based triplet regimens are effective in patients with R/R multiple myeloma - ASCO
ASCO shared on X: "The DREAMM-7 and DREAMM-8 studies established the effectiveness of belamaf-based triplet…
Jun 7, 2024, 14:45 |
Blog
Manni Mohyuddin on DREAMM-7
Manni Mohyuddin shared on X/Twitter: "In DREAMM-7 (bela/bort/dex vs dara/bort/dex). Only 34% of pts len refractory.…
Jun 2, 2024, 15:31 |
Insight
Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…
Jan 14, 2024, 17:54 |
Insight
Toni Choueiri: The February ASCO Plenary Series are here
Toni Choueiri posted on X/Twitter: "The February ASCO Plenary Series are here: Why??? Well...'Because Science can't…
All:
5
Posts:
1 - 100
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube